Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 2, 2007, Pages 221-227

  Cutrim, D M S L ^a   Pereira, F A ^a   de Paula, F J A ^a   Foss, M C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone markers; Bone mineral density; Diabetes mellitus; Glycemic control; Insulin like growth factor I; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; FOLLITROPIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; PROCOLLAGEN C PROTEINASE; SOMATOMEDIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MASS; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; FEMUR NECK; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; URINALYSIS; VITAMIN BLOOD LEVEL;

EID: 33846906468     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000200008     Document Type: Article

References (32)

1. Paula FJ, Foss MC. Muscle uptake of inorganic phosphorus during oral glucose challenge. Horm Metab Res 1990; 22: 506-507.
2. Kumar S, Olukoga AO, Gordon C, Mawer EB, France M, Hosker JP, et al. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol 1994; 40: 47-53.
3. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990; 33: 511-514.
4. Paula FJ, Plans AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998; 30: 281-284.
5. Kayath MJ, Dib AS, Vieira JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications 1998; 18: 97-104.
6. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999; 22: 1196-1200.
7. Sosa M, Dominguez M, Navarro MC, Segarra MC, Hernandez D, de Pablos P, et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J Diabetes Complications 1996; 10: 201-205.
8. Barrett-Connor E, Kritz-Silverstein D. Does hyperinsulinemia preserve bone? Diabetes Care 1996; 19: 1388-1392.
9. van Daele PL, Stolk RP, Burger H, Algra D, Grobbee DE, Hofman A, et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med 1995; 122: 409-414.
10. Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 1994; 23: 43-54.
11. Kwon DJ, Kim JH, Chung KW, Kim JH, Lee JW, Kim SP, et al. Bone mineral density of the spine using dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. J Obstet Gynaecol Res 1996; 22: 157-162.
12. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression on long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
13. U.K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
14. Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, et al. Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab 1992; 18: 32-37.
15. Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulin-like growth fact system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J Endocrinol 1998; 159: 297-306.
16. Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano P, Garcia-Cervigon AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 2000; 11: 455-459.
17. Rix M, Andreassen H, Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 1999; 22: 827-831.
18. Rachon D, Mysliwska J, Suchecka-Rachon K, Semetkowska-Jurkiewicz B, Zorena K, Lysiak-Szydlowska W. Serum interluekin-6 levels and bone mineral density at the femoral neck in post-menopausal women with type 1 diabetes. Diabet Med 2003; 20: 475-480.
19. McNair P, Madsbad S, Chriistiansen C, Christensen MS, Faber OK, Binder C, et al. Bone loss in diabetes: effects of metabolic state. Diabetologia 1979; 17: 283-286.
20. Monnier L, Colette C, Aguirre L, Sany C, Mirourze J. Intestinal and renal handling of calcium in human diabetes mellitus: influence of acute oral glucose loading and diabetic control. Eur J Clin Invest 1978; 8: 225-231.
21. McNair P, Madsbad S, Christensen MS, Christiansen C, Faber OK, Binder C, et al. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol 1979; 90: 463-472.
22. Piepkorn B, Kann P, Forst T, Andreas J, Pfutzner A, Beyer J. Bone mineral density and bone metabolism in diabetes mellitus. Horm Metab Res 1997; 29: 584-591.
23. Paula FJ, Lanna CM, Shuhama T, Foss MC. Effect of metabolic control on parathyroid hormone secretion in diabetic patients. Braz J Med Biol Res 2001; 34: 1139-1145.
24. Akin O, Gol K, Akturk M, Erkaya S. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 2003; 17: 19-29.
25. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993; 129: 393-398.
26. Ribot C, Tremollieres F, Pouilles JM, Bonneu M, Germain F, Louvet JP. Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone 1988; 8: 327-331.
27. Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol 1999; 51: 301-307.
28. Luisetto G, Bottega F, Nardi A, Ziliotto D. Decrease of bone formation in adult women with fragility fractures. Maturitas 1997; 28: 59-67.
29. Isaia GC, Ardissone P, Di Stefano M, Ferrari D, Martina V, Porta M, et al. Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 1999; 36: 35-38.
30. Yakar S, Rosen CJ. From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med 2003; 228: 245-252.
31. Cortizo AM, Lee PD, Cedola NV, Jasper H, Gagliardino JJ. Relationship between non-enzymatc glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus. Acta Diabetol 1998; 35: 85-90.
32. Frystyk J, Skjaerbaek C, Vestbo, E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999; 15: 314-322.